Telacebec (Q203)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Telacebec (Q203), covering 2019-09-10 to 2019-09-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203) [Phase 2]